US FDA’s Confidence In Gene Editing Safety Growing Enough That Regulatory Bar May Be Lowered

Some worries about heritable genetic modifications are subsiding and Center for Biologics Evaluation and Research Director Peter Marks said sponsors should consider the US for regulatory advice and clinical trials in the space.